Alcon to acquire LumiThera.

Alcon, a pharmaceutical and medical device company, agreed to acquire LumiThera, an ophthalmic medical device company. Financial terms were not disclosed. “For more than 25 years, Alcon has been a leader in vitreoretinal surgery, and we are excited to expand our offerings into the clinic, to help millions of people living with dry AMD gain vision. Dry AMD is an area of significant unmet need, and PBM is an efficacious, non-invasive light therapy that can provide visual improvement for patients with early and intermediate disease. With Alcon’s global commercial and clinical expertise, we have the potential to make this therapy more broadly available to Eye Care Professionals and their patients, while continuing to strengthen its body of clinical evidence," Sean Clark, Alcon Vice President and General Manager.